Amtec ready to take on US market:
This article was originally published in Clinica
Executive Summary
Northern Irish medical technology company Amtec (Antrim Technology Park) is gearing up to take on the US market armed with new expertise and insight about US FDA regulatory requirements. R&D manager Jonathan King returned recently from a six-month UK DTI-funded secondment at TriVirix International (Chapel Hill, North Carolina), where he learnt best practice approaches to getting products onto the US market in a reduced time. The DTI's International Technology Service defrayed the cost of the exercise to the tune of 50%. Eligible UK companies (under 250 employees) should contact Ron Kirby at the DTI's London offices on tel: +44 (0)20 7215 4117. www.globalwatchonline.com